Key Takeaways
- • CMS imposed nationwide six-month moratoria on new Medicare enrollments for hospices and home health agencies (HHAs) effective May 13, 2026, marking the third nationwide enrollment freeze in three months and signaling a structural shift in federal fraud enforcement strategy away from geographically-targeted restrictions.
- • Existing enrolled providers may continue operations and billing, but new applications submitted during the moratorium period will be denied; providers unable to enroll during the freeze face assignment to "high" categorical risk screening upon reapplication, triggering enhanced enrollment requirements and scrutiny.
- • CMS cited escalating DOJ criminal convictions and False Claims Act settlements as justification for nationwide action, identifying hospices and HHAs as among the highest fraud-risk provider categories, with specific concerns including improper terminal illness certifications, "churn and burn" schemes, and rapid fraudulent growth patterns.
- • The administration simultaneously announced withholding of $1.3 billion in Medicaid payments to California and warned all 50 state attorneys general of federal funding penalties for non-compliance with Medicaid antifraud statutes, indicating parallel state-level enforcement acceleration.
- • CMS plans to intensify targeted investigations, deploy advanced data analytics, and accelerate provider removals during the moratorium period; payment suspensions already reached $5.7 billion in 2025, with providers facing cash flow disruption based on "credible allegation of fraud" well before investigation conclusion.
Summary
On May 13, 2026, the Centers for Medicare & Medicaid Services (CMS) imposed two nationwide, six-month moratoria on new Medicare enrollments for hospice and home health agencies, effective immediately. The action, coordinated with Vice President JD Vance's Anti-Fraud Task Force, represents a significant escalation in federal healthcare fraud enforcement and marks the third nationwide provider enrollment freeze within three months, following CMS's February 2026 moratorium on durable medical equipment suppliers (DMEPOS). This pattern signals that nationwide moratoria have transitioned from exception to standard enforcement mechanism in the CMS compliance arsenal.
The moratoria prohibit new Medicare enrollments for hospices and HHAs nationwide, including new branches and practice locations established by existing providers and any enrollment changes triggered by majority ownership transitions. Critically, existing enrolled providers retain uninterrupted billing rights and may continue operations. Pending applications submitted before May 13 remain unaffected, but all applications filed during the six-month moratorium period will be denied and must be resubmitted after the freeze lifts. Upon reapplication post-moratorium, providers face mandatory assignment to "high" categorical risk screening under federal regulations, triggering heightened enrollment scrutiny and compliance requirements. CMS retains authority to extend moratoria in additional six-month increments and has limited appeal scope to whether the moratorium applies to individual providers—regulatory structure permits no exceptions.
CMS justified the nationwide action through Federal Register notices citing elevated program integrity risks. The agency identified HHAs as presenting "among the highest" fraud risks of any provider category, with "hundreds of millions of taxpayer dollars" threatened by fraudulent actors. Regarding hospices, CMS cited three specific fraud patterns: improper terminal illness certifications coupled with minimal or absent beneficiary services; rapid proliferation of potentially fraudulent hospices; and "churn and burn" schemes where entities bill aggressively until reaching statutory payment caps or triggering audits, then dissolve, retain funds, obtain new billing numbers, and transfer beneficiaries to restart the cycle. CMS explicitly cited increasing criminal convictions and FCA settlements as empirical evidence justifying nationwide rather than geographically-limited restrictions.
The enforcement posture extends beyond enrollment controls. CMS stated intentions to intensify investigations, deploy advanced data analytics, and accelerate provider removals during the moratorium period. This signals heightened scrutiny of billing patterns against national benchmarks, with anomalies in volume, frequency, and coding triggering pre-payment reviews or immediate payment suspensions. CMS suspended $5.7 billion in provider payments during 2025, including $1.5 billion tied to DMEPOS billing. Critically, suspensions can be imposed on "credible allegation of fraud" without awaiting investigation conclusion, creating immediate cash flow disruption risk. Contemporaneously, Vice President Vance warned all 50 state attorneys general of Medicaid funding penalties for non-compliance with antifraud statutes, with CMS currently withholding $1.3 billion from California and $260 million previously withheld from Minnesota. This multi-jurisdictional enforcement stance indicates probable acceleration of state-level Medicaid Fraud Control Unit investigations and state whistleblower actions alongside federal DOJ activity.
For healthcare investors and operators, the moratoria create near-term barriers to market entry and expansion while signaling sustained federal enforcement intensity. Ownership transitions, branch expansion, and new provider establishment face six-month suspension with elevated post-moratorium compliance burdens. Existing operators face enhanced surveillance through data analytics and elevated payment suspension risk. Congressional engagement, including House Ways and Means and House Energy and Commerce subcommittee hearings on fraud, combined with prominent anti-fraud language in CMS's FY2027 budget justification sent to Congress in April 2026, suggests legislative action remains possible alongside administrative enforcement acceleration.
The moratoria prohibit new Medicare enrollments for hospices and HHAs nationwide, including new branches and practice locations established by existing providers and any enrollment changes triggered by majority ownership transitions. Critically, existing enrolled providers retain uninterrupted billing rights and may continue operations. Pending applications submitted before May 13 remain unaffected, but all applications filed during the six-month moratorium period will be denied and must be resubmitted after the freeze lifts. Upon reapplication post-moratorium, providers face mandatory assignment to "high" categorical risk screening under federal regulations, triggering heightened enrollment scrutiny and compliance requirements. CMS retains authority to extend moratoria in additional six-month increments and has limited appeal scope to whether the moratorium applies to individual providers—regulatory structure permits no exceptions.
CMS justified the nationwide action through Federal Register notices citing elevated program integrity risks. The agency identified HHAs as presenting "among the highest" fraud risks of any provider category, with "hundreds of millions of taxpayer dollars" threatened by fraudulent actors. Regarding hospices, CMS cited three specific fraud patterns: improper terminal illness certifications coupled with minimal or absent beneficiary services; rapid proliferation of potentially fraudulent hospices; and "churn and burn" schemes where entities bill aggressively until reaching statutory payment caps or triggering audits, then dissolve, retain funds, obtain new billing numbers, and transfer beneficiaries to restart the cycle. CMS explicitly cited increasing criminal convictions and FCA settlements as empirical evidence justifying nationwide rather than geographically-limited restrictions.
The enforcement posture extends beyond enrollment controls. CMS stated intentions to intensify investigations, deploy advanced data analytics, and accelerate provider removals during the moratorium period. This signals heightened scrutiny of billing patterns against national benchmarks, with anomalies in volume, frequency, and coding triggering pre-payment reviews or immediate payment suspensions. CMS suspended $5.7 billion in provider payments during 2025, including $1.5 billion tied to DMEPOS billing. Critically, suspensions can be imposed on "credible allegation of fraud" without awaiting investigation conclusion, creating immediate cash flow disruption risk. Contemporaneously, Vice President Vance warned all 50 state attorneys general of Medicaid funding penalties for non-compliance with antifraud statutes, with CMS currently withholding $1.3 billion from California and $260 million previously withheld from Minnesota. This multi-jurisdictional enforcement stance indicates probable acceleration of state-level Medicaid Fraud Control Unit investigations and state whistleblower actions alongside federal DOJ activity.
For healthcare investors and operators, the moratoria create near-term barriers to market entry and expansion while signaling sustained federal enforcement intensity. Ownership transitions, branch expansion, and new provider establishment face six-month suspension with elevated post-moratorium compliance burdens. Existing operators face enhanced surveillance through data analytics and elevated payment suspension risk. Congressional engagement, including House Ways and Means and House Energy and Commerce subcommittee hearings on fraud, combined with prominent anti-fraud language in CMS's FY2027 budget justification sent to Congress in April 2026, suggests legislative action remains possible alongside administrative enforcement acceleration.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.